Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Cardiometabolic Health
Cardiometabolic Health
Cardiovascular data confirm metformin over sulfonylurea as initial treatment choice in type 2 diabetes
Wayne Kuznar
Read More
Cardiometabolic Health
Alternative Anticoagulants to Warfarin Reduce Vascular Risk in Patients with NVAF
Wayne Kuznar
Read More
Cardiometabolic Health
PHS II: Cardiovascular Events in Men Not Reduced with Multivitamins
Mary Mosley
Read More
Cardiometabolic Health
Interventions for Cardiovascular Risk Reduction in Type 2 Diabetes Must Be Multifactorial
Wayne Kuznar
Read More
Cardiometabolic Health
Third Definition of Myocardial Infarction Presented at ESC 2012, Focusing on New High-Sensitivity Biomarkers
Mary Mosley
Read More
Cardiometabolic Health
Encouraging Data Reveal Potential Cardioprotective Role for DPP-4 Inhibitors
Read More
Cardiometabolic Health
Several Antihypertensive Drug Combinations Increase the Risk for Incident Diabetes
Wayne Kuznar
Read More
Cardiometabolic Health
Control of 4 Risk Factors Would Slash CHD Rate in Diabetes by Half
Wayne Kuznar
Read More
Cardiometabolic Health
Sustained Glycemic Control with Once-Weekly Exenatide Reduces Cardiometabolic Risk Factors
Mary Mosley
Read More
Cardiometabolic Health
Incretin Therapies Lower Cardiovascular Risk Score
Wayne Kuznar
Read More
1
2
3
Page 1 of 3
Results 1 - 10 of 28
